Saverio Alvaro

Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study

Francesco Carubbi, Paola Cipriani, Alessandra Marrelli et al. · Arthritis Research & Therapy · 2013 · 178 citations · Full text

Life Sciences, Immunology, Internal Medicine +14

Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trial

Piero Ruscitti, Francesco Masedu, Saverio Alvaro et al. · PLoS Medicine · 2019 · 133 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1<b>β</b>via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a possible implication for therapeutic decision in these patients

Piero Ruscitti, Paola Cipriani, Paola Di Benedetto et al. · Clinical & Experimental Immunology · 2015 · 131 citations · Full text

Veterinary Medicine, Cell Biology, Immunology +17

Scleroderma Mesenchymal Stem Cells display a different phenotype from healthy controls; implications for regenerative medicine

Paola Cipriani, Alessandra Marrelli, Paola Di Benedetto et al. · Angiogenesis · 2013 · 64 citations

Life Sciences, Cell Biology, Cell Therapy +11

Increased Cardiovascular Events and Subclinical Atherosclerosis in Rheumatoid Arthritis Patients: 1 Year Prospective Single Centre Study

Piero Ruscitti, Paola Cipriani, Francesco Masedu et al. · PLoS ONE · 2017 · 48 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +12